BioSpace News Archive

Policy

4 Strategies to Harden the Pharma Supply Chain Before Federal Mandates Kick In

Change is coming to the pharmaceutical supply chain. The supply chain review ordered by President Biden virtually guarantees it with its attempts to understand and improve issues related to supply chain transparency, security and overreliance on a few suppliers in a few regions.

March 23, 2021
·
5 min read
·
Gail Dutton
Drug Development

Roche Puts the Kibosh on Trial of Huntington’s Drug Tominersen

Ionis Pharmaceuticals announced that its collaboration partner, Roche, was discontinuing dosing in the Phase III GENERATION HD1 trial of tominersen in manifest Huntington’s disease (HD).

March 23, 2021
·
3 min read
·
Mark Terry
Deals

Four More Biopharma Companies Set Sights on IPOs

This week, four companies set sights on listing their shares on the stock market in hopes of raising significant funds to support the development of their pipelines and businesses.

March 23, 2021
·
3 min read
·
Alex Keown
Business

Two Cell Therapy Companies Bag New CEOs

AlloVir and Abeona Therapeutics have both appointed new chief executive officers. Here’s a look.

March 23, 2021
·
3 min read
·
Alex Keown
News Brief – FDA Slapdown, Patent Approval, Funding News and More

The life sciences industry is a bustling beehive of activity. Here’s a quick compilation of some of today’s newsworthy announcements.

March 23, 2021
·
3 min read
·
Kate Goodwin
FDA

Merck Scores Latest Label Expansion for Keytruda in Esophageal Carcinomas

Keytruda (pembrolizumab) won another regulatory victory, making it the first checkpoint inhibitor approved by the U.S. FDA for first line treatment of patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinomas regardless of PD-L1 expression.

March 23, 2021
·
2 min read
·
Mark Zipkin
Business

From Hong Kong to Boston, New Biopharma Launches with Immune-based Pipeline

Zenas BioPharma announced it has launched a cross-border biopharmaceutical company based in both China and the U.S.

March 23, 2021
·
3 min read
·
Brandon May
Business

Money on the Move: March 17-23

It’s March Madness in the life sciences industry, with money pouring in faster than LeBron James on a breakaway. Here’s where the big bucks went this week.

March 23, 2021
·
6 min read
·
Kate Goodwin
Drug Development

U.S. Officials: AstraZeneca May Have Provided Outdated Data for COVID-19 Vaccine

The announcement by the NIAID, a part of the National Institutes of Health (NIH), is very unusual.

March 23, 2021
·
5 min read
·
Mark Terry
Drug Development

Novartis’ Radioligand Therapy Lives Up to Hype in Phase III Prostate Cancer Trial

Targeted radioligand therapy 177Lu-PSMA-617 from Novartis significantly improved overall survival (OS) and radiographic progression-free survival (rPFS) in patients with PSMA-positive metastatic castration-resistant prostate cancer.

March 23, 2021
·
3 min read
·
Brandon May